Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future ...
Microbot won FDA 510(k) clearance for its LIBERTY Endovascular Robotic System. MBOT shares jumped 22.9% after the announcement and are up 301.8% year to date. The LIBERTY system is compact, disposable ...
Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...
Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results